• Issue

    Clinical and Experimental Neuroimmunology: Volume 12, Issue 3

    141-207
    August 2021

ISSUE INFORMATION

Free Access

Issue Information

  • Pages: 141-143
  • First Published: 27 August 2021

NEW DEVELOPMENTS IN NEUROIMMUNOLOGY

Interleukin-19 ameliorates experimental autoimmune encephalitis

  • Pages: 148-149
  • First Published: 29 March 2021
Interleukin-19 ameliorates experimental autoimmune encephalitis

Interleukin-19 serves as a negative feedback regulator to limit the pro-inflammatory response of macrophages and microglia in autocrine/paracrine manners. Interleukin-19 suppresses microglia/macrophage antigen presentation, T helper 17 cell expansion and subsequent inflammation in the central nervous system, resulting in improvement in experimental autoimmune encephalomyelitis.

FOCUSED REVIEW SERIES ON EMERGING TOPICS ON GUILLAIN-BARRE SYNDROME

REVIEW ARTICLES

Anti-GQ1b antibody: Recent topics

  • Pages: 158-164
  • First Published: 23 July 2021
Anti-GQ1b antibody: Recent topics

The latest topics are described regarding anti-GQ1b antibody, which is a diagnostic marker for Fisher syndrome, including Ca2+-dependent anti-GQ1b antibodies. Although the same anti-GQ1b antibody was positive, the clinical feature was different between the Ca2+-dependent antibody and the Ca2+-independent group.

Emerging infectious diseases, vaccines and Guillain–Barré syndrome

  • Pages: 165-170
  • First Published: 23 April 2021
Emerging infectious diseases, vaccines and Guillain–Barré syndrome

In this article, we review the evidence regarding the relationship between emerging infectious diseases (such as Zika virus infection and coronavirus disease 2019) and Guillain–Barré syndrome. The contemporary knowledge about post-vaccination Guillain–Barré syndrome is also summarized.

MS/NMO AND ALLIED DISORDERS

CASE REPORT

Pregnancy in multiple sclerosis: A reflection on the importance of individualizing management

  • Pages: 171-174
  • First Published: 09 December 2020
Pregnancy in multiple sclerosis: A reflection on the importance of individualizing management

We present two cases of active relapse-remitting multiple sclerosis in pregnant women with different clinical courses, mirroring the disease heterogeneity and unpredictability. The decision of maintaining disease-modifying therapy throughout gestation could be a strategy to reduce postpartum relapses.

MUSCLE DISEASE

CLINICAL LETTER

Fatal fulminant inflammation in the diaphragm resulting from pembrolizumab-related myopathy

  • Pages: 179-181
  • First Published: 30 March 2021
Fatal fulminant inflammation in the diaphragm resulting from pembrolizumab-related myopathy

The pathological investigations of the fatal fulminant inflammation in the diaphragm resulting from Pembrolizumab-related myopathy. Histologically, diaphragm demonstrated massive infiltration of inflammatory cells and muscle fiber necrosis.The mechanisms that explain the generation of PD-1 nyopathy are still unknown. We should therefore always pay close attention to the neuromuscular symptoms of patients treated with ICIs.

NEUROSCIENCE AND NEURODEGENERATIVE DISORDERS

REVIEW ARTICLE

Cognition and psychopathology in autoimmune encephalitides: A focus on risk factors and patient outcomes

  • Pages: 182-191
  • First Published: 06 June 2021
Cognition and psychopathology in autoimmune encephalitides: A focus on risk factors and patient outcomes

Neurocognitive compromise, neuropsychiatric symptoms and psychopathology are all evident in autoimmune encephalitides. This review provides detailed analysis of the various cognitive deficits and psychopathology that occur in different subsets of autoimmune encephalitides . It also delves into the implication of the aforementioned in regard to patient quality of life and overall prognosis.

IMMUNOLOGY AND OTHER INFLAMMATORY DISORDERS

ORIGINAL ARTICLE

Open Access

Differential production of interleukin-6 and tumor necrosis factor-α in primary rat astrocyte cultures using two distinct methods of microglia elimination

  • Pages: 192-201
  • First Published: 22 May 2021
Differential production of interleukin-6 and tumor necrosis factor-α in primary rat astrocyte cultures using two distinct methods of microglia elimination

This study examines the effect of the most important factors involved in hepatic encephalopathy on the production of reactive oxygen species and cytokines such as tumor necrosis factor-α and interleukin-6 in highly purified primary rat astrocyte cultures. Results demonstrated that manganese evoked oxidative stress in a time-dependent manner. The cytokine production proved to be influenced by the type of the microglia elimination procedure.

REVIEW ARTICLE

Methodology for identification of new target molecules in neuroimmunological disorders

  • Pages: 202-207
  • First Published: 04 May 2021
Methodology for identification of new target molecules in neuroimmunological disorders

Recent advances of proteomic technologies enable scientists to determine the target protein of autoantibodies in neuroimmunological disorders. These methods are divided into three categories, namely, (1) mass spectrometry–based method, (2) gene expression library screening, and (3) protein microarray. A sound knowledge of the advantages and limitations of each technique is required for selection of the optimal methodology for antigen identification.